Medical complications of stimulant use
| Organ system | Acute complications | Chronic complications | 
|---|---|---|
| Central nervous system | Hallucinations, esp. tactile | Psychotic symptoms | 
| Dyskinesia | Cerebrovascular disease/stroke | |
| Seizures | Movement disorders, e.g., dystonic reactions, akathisia, choreoathetosis, tardive dyskinesia | |
| Cardiovascular system | Tachycardia | Myocarditis | 
| Hypertension | Cardiomyopathy | |
| Myocardial infarction | Myocardial fibrosis | |
| Arrhythmias | Myocardial infarction | |
| Pulmonary | Cough, shortness of breath, wheezing | Interstitial pneumonitis | 
| Pulmonary edema, hemorrhage | Bronchiolitis obliterans | |
| Pneumothorax | ||
| Renal | Renal ischemia | |
| Renal failure | ||
| Gastrointestinal | Reduced gastric motility | Gastric ulceration and perforation | 
| Intestinal infarction | ||
| Ischemic colitis | ||
| Liver | Viral hepatitis secondary to contaminated syringe use | |
| Endocrine | Reduced prolactin | Inc, normal or dec. prolactin | 
| Increased epinephrine, CRH, ACTH, cortisol and luteinizing hormones | Normal testosterone, cortisol, LH, thyroid hormones | |
| Musculoskeletal | Movement disorders (see CNS) | Rhabdomyolysis | 
| Head and neck | Rhinitis | Rhinitis | 
| Perforated nasal septum | ||
| Nasal and gingival ulceration | ||
| Sinusitis | ||
| Dental decay and periodontal disease | ||
| Xerostomia | ||
| Corneal ulcers | ||
| Immune system | Vasculitis sysndromes | |
| Sexual function | Erectile dysfunction | |
| Irregular menses | ||
| Reproductive | Vaginal bleeding | FDA category C | 
| Abruption placenta | Placenta previa | |
| Premature rupture of membranes | Low birth weight | |
| General/other | Dehydration | Weight loss | 
| Nutritional deficits |